October 14, 2010 — The US Food and Drug Administration (FDA) has granted humanitarian use device designation for a diaphragm pacing system (NeuRx; Synapse Biomedical, Inc) in patients with amyotrophic ...
April 19, 2005 — Implantation of a minimally invasive diaphragm pacing system (DPS) with therapeutic electrostimulation may help maintain diaphragm function and slow or arrest the rate of respiratory ...
An electronic system that stimulates the nerve of the diaphragm muscles has received approval from the Food and Drug Administration (FDA) for use in patients with Amyotrophic Lateral Sclerosis (ALS), ...
OBERLIN, Ohio, April 5, 2023 /PRNewswire/ -- Synapse Biomedical, Inc. announced today that the FDA has granted premarket approval (PMA) of the NeuRx ® Diaphragm Pacing System (NeuRx DPS ®) for use in ...
In order to introduce the ‘path-breaking’ procedure of diaphragmatic pacing in India, Indian Spinal Injuries Centre (ISIC) has tied up with leading American gastrointestinal surgeon. With its ...
Oberlin-based Synapse Biomedical recently secured U.S. Food and Drug Administration premarket approval for its diaphragm pacing system for use in patients with spinal cord injuries (SCI) who rely on ...
Please provide your email address to receive an email when new articles are posted on . Synapse Biomedical has received premarket approval from the FDA for its NeuRx Diaphragm Pacing System, which ...
Dublin, Feb. 23, 2024 (GLOBE NEWSWIRE) -- The "Diaphragm Pacing Therapy System Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ...
Pune, Maharashtra, India, December 10 2020 (Wiredrelease) Brandessence Market Research and Consulting Pvt ltd –:Diaphragm Pacing Therapy System Market is valued at USD 4.82 Million in 2018 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results